UOC
PTLA

UBS O'Connor’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

UBS O'Connor’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-204,017
Closed -$3.67M – 453
2020
Q2 		$3.67M Buy
+204,017
New +$2.84M 0.08% 180

UBS O'Connor's PTLA Position: Q3 2020 in Review

UBS O'Connor sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 204,017 shares — an estimated $3.67M sold.

UBS O'Connor first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $3.67M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • UBS O'Connor reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • UBS O'Connor sold 204,017 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $3.67M.
  • UBS O'Connor first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • UBS O'Connor's Portola Pharmaceuticals, Inc. position peaked at $3.67M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on UBS O'Connor's 13F filing for Q3 2020, filed 12 Nov 2020.